Temporary Mechanical Circulatory Support in Cardiogenic Shock: Optimizing Outcomes

This session delves into the complex challenges of CS management, focusing on the use of temporary MCS devices and patient selection. The session will spotlight current trends and existing evidence for temporary MCS utilization in cardiogenic shock and will explore the critical unanswered questions in the field. We will also address the management of extra-cardiac complications, including non-cardiac organ dysfunction and infection, and discuss the importance of active strategies for weaning temporary MCS devices.

Agenda

• Moderator - Thomas Hanff, MD, MPH, FHFSA
• Moderator - Daniel Burkhoff, MD
• Powering the Failing Heart: The Latest Tools and Trends in Temporary MCS - Mir Basir, DO
• Intersection of Man and Machine: Patient Selection and Management in tMCS - Shelley Hall, MD, FHFSA
• Unpacking the Data: Key Takeaways from Randomized Trials of Temporary MCS - Jane Wilcox, MD
• Beyond the Heart: Managing Extracardiac Complications in CS and tMCS - Ran Lee, MD
• From Support to Stability: Weaning Patients Off Temporary MCS - Varinder Randhawa, MD, PhD
• Panel Discussion